| # | Drug | Count |
|---|---|---|
| 0 | OLANZAPINE | 133 |
| 1 | OLANZAPINE PAMOATE | 128 |
| 2 | NIVOLUMAB | 108 |
| 3 | IPILIMUMAB | 96 |
| 4 | FINASTERIDE | 83 |
| 5 | PEMBROLIZUMAB | 72 |
| 6 | ATEZOLIZUMAB | 59 |
| 7 | LEVOTHYROXINE SODIUM | 46 |
| 8 | ERGOCALCIFEROL | 43 |
| 9 | ACETAMINOPHEN | 37 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETIBEGLOGENE AUTOTEMCEL | 10 | 0.1786 |
| 1 | PRAMLINTIDE ACETATE | 3 | 0.0294 |
| 2 | L-PHENYLALANINE | 1 | 0.0127 |
| 3 | SOMAPACITAN-BECO | 2 | 0.0110 |
| 4 | CEFACLOR | 11 | 0.0071 |
| 5 | METHENAMINE MANDELATE | 1 | 0.0053 |
| 6 | PEGFILGRASTIM-APGF | 1 | 0.0051 |
| 7 | COSYNTROPIN | 1 | 0.0045 |
| 8 | AVOBENZONE, HOMOSALATE, OCTISALATE, AND OCTOCRYLENE | 1 | 0.0039 |
| 9 | CHROMIC CHLORIDE | 3 | 0.0035 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 173 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 168 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 101 |
| 3 | Corticosteroid [EPC] | 94 |
| 4 | 5-alpha Reductase Inhibitor [EPC] | 83 |
| 5 | Benzodiazepine [EPC] | 74 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 67 |
| 7 | Proton Pump Inhibitor [EPC] | 49 |
| 8 | Platinum-based Drug [EPC] | 44 |
| 9 | Provitamin D2 Compound [EPC] | 43 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiseptic [EPC] | 11 | 0.0025 |
| 1 | Leptin Analog [EPC] | 3 | 0.0024 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 101 | 0.0021 |
| 3 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 168 | 0.0017 |
| 4 | Programmed Death Ligand-1 Blocker [EPC] | 32 | 0.0015 |
| 5 | Provitamin D2 Compound [EPC] | 43 | 0.0014 |
| 6 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 7 | 5-alpha Reductase Inhibitor [EPC] | 83 | 0.0008 |
| 8 | Recombinant Human Growth Hormone [EPC] | 15 | 0.0007 |
| 9 | Iron Chelator [EPC] | 17 | 0.0006 |